TRPM8 antagonist 4
TRPM8 antagonist 4 is a CB2R partial agonist (EC50=54.2 nM, Ki=3.2 μM) and TRPM8 antagonists (IC50=42.3 nM) with high functional selectivity and good physicochemical properties. TRPM8 antagonist 4 has significant anti-inflammatory and analgesic effects and good safety, reduces the mRNA expression of TNF-α, IL-6, and IL-1β[1].
Product Specifications
UNSPSC
12352005
Target
Cannabinoid Receptor; Interleukin Related; TNF Receptor; TRP Channel
Related Pathways
Apoptosis; GPCR/G Protein; Immunology/Inflammation; Membrane Transporter/Ion Channel; Neuronal Signaling
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Smiles
O=C(N)C1=C(O)C=C(OC/C=C(C)/CC/C=C(C)/C)C=C1C2CC2
Molecular Formula
C20H27NO3
Molecular Weight
329.43
References & Citations
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
CB2; IL-1; IL-6; TNFRSF5/CD40; TRPM8
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Cytokeratin 20 (KRT20) (Colorectal Epithelial Marker) (KRT20/1992), CF740 conjugate, 0.1mg/mL
AIF1 / Iba1 (Microglia Marker) (AIF1/2493), 1mg/mL
Human COL5α2 (Collagen Type V Alpha 2) CLIA Kit
Human COL5α2 (Collagen Type V Alpha 2) CLIA Kit
Human COL5α2 (Collagen Type V Alpha 2) CLIA Kit
